给编辑的回信。 - Suppr

Suppr

超能文献

Response letter to the editor.

作者信息

Jarošová Jana, Hucl Tomas

机构信息

Gastroenterology and Hepatology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.

Gastroenterology and Hepatology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic

出版信息

Gut. 2025 Feb 6;74(3):501. doi: 10.1136/gutjnl-2023-331758.

DOI:10.1136/gutjnl-2023-331758

PMID:39632057

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11874364/

Abstract

摘要

相似文献

Response letter to the editor.

Gut. 2025 Feb 6;74(3):501. doi: 10.1136/gutjnl-2023-331758.

Reply, Letter to the Editor - The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.

Clin Nutr. 2016 Jun;35(3):765-6. doi: 10.1016/j.clnu.2016.03.006. Epub 2016 Mar 17.

Response to a letter to the editor: UroVysion FISH for diagnosing cholangiocarcinoma.

Diagn Cytopathol. 2014 May;42(5):459. doi: 10.1002/dc.22882. Epub 2012 Jun 19.

Letter to the Editor: Enhancing the rigor and impact of cholangiocarcinoma research: Addressing key concerns in the PTPN9-FGFR2 interaction study.

Hepatology. 2024 Sep 1;80(3):E44-E45. doi: 10.1097/HEP.0000000000000932. Epub 2024 Jun 24.

Letter to the Editor: EUS-FNA for Lymph Nodes Staging in Cholangiocarcinoma: Should It Become Standard of Care?

Hepatology. 2020 Oct;72(4):1496. doi: 10.1002/hep.31266.

Letter to the Editor: Short- and Long-Term Outcomes of Liver Resection for Intrahepatic Cholangiocarcinoma Associated with the Metabolic Syndrome.

World J Surg. 2020 Mar;44(3):1002-1003. doi: 10.1007/s00268-019-05318-y.

Letter to the Editor: The Role of Surgery in Multiple Intrahepatic Cholangiocarcinoma Should Not Be Dismissed Without Further Analysis.

Hepatology. 2021 Oct;74(4):2318-2319. doi: 10.1002/hep.31905. Epub 2021 Aug 22.

Letter to the Editor: Does Multiple Intrahepatic Cholangiocarcinoma Worsen Prognosis as "M1" Stage?

Hepatology. 2021 Aug;74(2):1128. doi: 10.1002/hep.31741. Epub 2021 Jun 18.

Response to the letter to the editor on the article: radiomics nomogram based on optimal VOI of multi-sequence MRI for predicting microvascular invasion in intrahepatic cholangiocarcinoma.

Radiol Med. 2024 May;129(5):818-821. doi: 10.1007/s11547-024-01799-7. Epub 2024 Mar 21.

Letter to the Editor: How to define the futile outcome in patients undergoing surgery for perihilar cholangiocarcinoma?

Hepatology. 2024 Feb 1;79(2):E22-E23. doi: 10.1097/HEP.0000000000000651. Epub 2023 Nov 7.

本文引用的文献

Time to focus on the real potential benefit of endobiliary radiofrequency ablation: stent patency in patients with cholangiocarcinoma.

Gut. 2024 Sep 9;73(10):e11. doi: 10.1136/gutjnl-2023-331359.

Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial.

Gut. 2023 Nov 24;72(12):2286-2293. doi: 10.1136/gutjnl-2023-329700.

Long-term efficacy of metal versus plastic stents in inoperable perihilar cholangiocarcinoma; a multicenter retrospective propensity score matched comparison.

HPB (Oxford). 2023 Jul;25(7):798-806. doi: 10.1016/j.hpb.2023.03.011. Epub 2023 Mar 23.

Impact of endobiliary radiofrequency ablation on biliary drainage in patients with malignant biliary strictures treated with uncovered self-expandable metal stents: a randomized controlled multicenter trial.

Gastrointest Endosc. 2022 Dec;96(6):970-979. doi: 10.1016/j.gie.2022.05.022. Epub 2022 Jun 3.

Endoscopic radiofrequency ablation plus plastic stent placement versus stent placement alone for unresectable extrahepatic biliary cancer: a multicenter randomized controlled trial.

Gastrointest Endosc. 2021 Jul;94(1):91-100.e2. doi: 10.1016/j.gie.2020.12.016. Epub 2020 Dec 24.

Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIAL.

Surg Endosc. 2021 Jan;35(1):63-73. doi: 10.1007/s00464-020-07689-z. Epub 2020 Jun 2.

Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial.

Endoscopy. 2018 Aug;50(8):751-760. doi: 10.1055/s-0043-124870. Epub 2018 Jan 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验